Task: Answer the multiple-choice question.
Question: Which compound exhibits a 8.535% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) C[C@H](NC(=O)C1CC(=O)N(c2ccc(F)cc2)C1)C(=O)N1CCCCC1
(b) CCOC(=O)c1cc2c(=O)n3ccccc3nc2n(CCOC)c1=NC(=O)C(C)(C)C
Answer: a. C[C@H](NC(=O)C1CC(=O)N(c2ccc(F)cc2)C1)C(=O)N1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C[C@H](NC(=O)C1CC(=O)N(c2ccc(F)cc2)C1)C(=O)N1CCCCC1
C[C@H](NC(=O)C1CC(=O)N(c2ccc(F)cc2)C1)C(=O)N1CCCCC1
1-(4-fluorophenyl)-5-oxo-N-[(2S)-1-oxo-1-piperidin-1-ylpropan-2-yl]pyrrolidine-3-carboxamide